Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117169) titled 'A Study on the Correlation Between Serum-Derived Biomarkers and Prognosis in Heart Failure Patients' on Jan. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Northern Jiangsu People's Hospital
Condition:
Heart failure
Intervention:
Good Prognosis Group:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-01-20
Target Sample Size: Good Prognosis Group:250;Poor Prognosis Group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=306505
Disclaimer: Curated by HT Syndication....